News
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These two reliable and high-yielding dividend payers from the healthcare sector should be on your buy list today.
MSD – known as Merck & Co in the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has been ...
4h
ThePrint on MSNBlockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunityPharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...
Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically ...
The UK’s National Institute for Health and Care Excellence (NICE) on August 6 recommended the use of US pharma giant Merck & ...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...
The highest-paying dividend stocks in the Dow Jones Industrial Average right now are Verizon Communications (NYSE: VZ), ...
MRK scores an A+ grade for Profitability, aided by high gross and EBITDA margins of 78% and 46%, respectively. Moreover, it ...
A new treatment for advanced endometrial cancer has been approved for use on the NHS, after women with the disease were found ...
Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results